Q32 Bio (QTTB)Chief Scientific Officer sold ~$5.4K

~$5.4K

Approx. value · 2,990 sh @ $1.80

58K

Holds after · shares reported

Traded

Aug 26, 2025

Filed

Aug 28, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 26, 2025 · this disclosureInsiderOfficer sold ~$5.4K of QTTB shares in the open market

What came next

1. Aug 26, 2025Insider · 2 peopleInsiders: 2 sales (~$27K)
2. Nov 13, 2025Company filing · Form 8-K · ResultsReported its results
3. Nov 28, 2025Company filing · Form 8-K · Material agreement, Agreement endedCompleted buying or selling a business or assets, and signed an important agreement (and 3 more items)“On December 1, 2025, the Company issued a press release announcing the ADX-097 Asset Sale disclosed under Item 1.01 of this Current Report on Form 8-K. A copy of the press release is furnished as Exhibit 99.1 to this report.”
4. Dec 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Mark Iwicki had previously notified Q32 Bio Inc. (the “Company”) of his intention to resign from the Company’s Board of Directors (the “Board”), effective as of December 31, 2025, to reduce the number of boards he serves on and to focus on his role as Chief Executive Officer of Inhibikase Therapeutics, Inc. Given the recently reduced number of boards on which Mr. Iwicki serves on, Mr. Iwicki, with the full support…”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Q32 Bio

For Q32 Bio, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its QTTB page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Q32 Bio

• SEC Schedule 13GOct 9, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Aug 28, 2025
• SEC Form 4Aug 28, 2025

Everything OQRO holds on this company is on its QTTB page.